Most Read Articles
Stephen Padilla, 06 Aug 2020
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
06 Aug 2020
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.

Novel microfluidic device detects CTCs expressing cancer stem cell marker in HCC

Stephen Padilla
07 Jan 2020

A new Labyrinth microfluidic device, coupled with three clinically validated markers, isolates and quantifies circulating tumour cells (CTCs) from blood samples of patients with hepatocellular carcinoma (HCC), reports a study.

“Our methodology markedly improved the capability to isolate heterogeneous HCC CTCs with high recovery rate and purity among all label-free technologies,” the researchers said.

“The device was able to detect CTCs in the majority of patients with HCC, and the positivity rate of HCC CTCs was significantly correlated with HCC disease stages, demonstrating the clinical potential for early detection, treatment selection and monitoring response to targeted therapies,” they added.

The novel Labyrinth microfluidic device was developed and optimized to efficiently isolate CTCs from peripheral blood of patients with HCC. It successfully identified CTCs in 88.1 percent of patients over different tumour stages. The CTC positivity rate was significantly higher in those with more advanced HCC stages. [Sci Rep 2019;9:18575]

Of the HCC patients, 71.4 percent exhibited CTCs positive for the cancer stem cell marker CD44, which indicated that the major population of CTCs could possess stemness properties to facilitate tumour cell survival and dissemination. In addition, more than half (55 percent) had the presence of circulating tumour microemboli (CTM), which also correlated with advanced HCC stage. This suggested the association of CTM with tumour progression.

CTM or CTC clusters that were observed in all HCC stages could provide additional survival signal and metastasis potential, the researchers said. [Phys Biol 2012;9:016001; Cancer Res 2017;77:5194-5206]

“Importantly, the detection of CTCs with stemness markers and CTM provides unique insights into the biology of CTCs and their mechanisms influencing metastasis, recurrence and therapeutic resistance,” they added.

Label-free, size-based microfluidic devices are useful in improving HCC CTC detection rate, identifying different HCC CTCs and allowing future downstream analysis capacity. Size-based CTC isolation devices consist of filtration and inertial methods, the researchers noted. [Clin Cancer Res 2015;21:4786-4800]

However, filtration approaches struggle with pore clogging and high-pressure drop, potentially causing cell damage and encountering CTC loss from forcing the cells to squeeze through the pores, which limits throughput and the amount of blood being processed, they said.

Alternatively, other approaches apply inertial forces to isolate CTCs with high-throughput capacity using sinusoidal or spiral channel geometries.

“Our high-throughput label-free Labyrinth device has demonstrated successful enrichment of CTCs from patients with breast cancer and pancreatic cancer,” the researchers said. “The Labyrinth offers unique features over previous inertial devices by incorporating 56 sharp corners that allows focusing of smaller cells which was difficult to achieve using previous technology.” [Cell Syst 2017;5:295-304]

One of the most lethal cancers, HCC has a high mortality and recurrence rate. CTC detection offers various opportunities to advance early detection as well as HCC tumour monitoring, which is key to improving patient outcome, according to the researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 06 Aug 2020
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
06 Aug 2020
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.
Stephen Padilla, 3 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.